The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of AbbVie's (ABBV) JAK inhibitor RINVOQ (upadaciti
Amid concerns about its $63 billion Allergan buyout, is now a good time to invest in the pharmaceutical giant?
Here's a roundup of top developments in the ...Full story available on Benzinga.com
Friday, October 18, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks,...
AstraZeneca (NYSE:AZN) and its Japanese partner Daiichi Sankyo Company announced that the FDA has granted priority review to the biologics license application (“BLA”)...
This week marked the start of the third-quarter earnings season for the pharma space with J&J (NYSE:JNJ) releasing its earnings. Roche (OTC:RHHBY) reported sales results...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Sell||Sell||Strong Buy||Strong Buy||Strong Sell|
|Summary||Strong Sell||Neutral||Strong Buy||Strong Buy||Neutral|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Inside Up||5H||2||Oct 18, 2019 08:00AM|
|Doji Star Bearish||1W||3||Sep 29, 2019|
|Doji Star Bearish||1H||4||Oct 18, 2019 12:00PM|
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.